Why the study?
Does glibenclamide prevent hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model of severe hypoglycemia?
Does glibenclamide prevent hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model of severe hypoglycemia?
Glibenclamide demonstrates a paradoxical protective role against severe hypoglycemia-induced fatal cardiac arrhythmias and mortality in a rat model.
No takes yet. Share an insight, caveat, or question.
May protect against fatal arrhythmias during severe hypoglycemia; leaves open whether KATP modulation alters sudden death risk in diabetes.
Reno et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: